161 related articles for article (PubMed ID: 9923721)
41. Effect of prostaglandins I2 (prostacyclin) and F2 alpha on function, energy metabolism, and calcium uptake in ischaemic/reperfused hearts.
Karmazyn M; Tani M; Neely JR
Cardiovasc Res; 1993 Mar; 27(3):396-402. PubMed ID: 8490938
[TBL] [Abstract][Full Text] [Related]
42. Spectroscopy of the isolated rabbit heart: effects of perfusion with oxygenated crystalloid cardioplegia at 4 degrees C and 20 degrees C.
Shorr LD; Thompson RT; Marsh GD; Driedger AA; Magilligan DJ
Can J Cardiol; 1991 Apr; 7(3):155-60. PubMed ID: 2044019
[TBL] [Abstract][Full Text] [Related]
43. Optimal level of hypothermia for prolonged myocardial protection assessed by 31P nuclear magnetic resonance.
Karck M; Vivi A; Tassini M; Schwalb H; Askenasy N; Merchav H; Navon G; Uretzky G
Ann Thorac Surg; 1992 Aug; 54(2):348-51. PubMed ID: 1637231
[TBL] [Abstract][Full Text] [Related]
44. Metabolic and functional effects of low-potassium cardioplegic solutions for long-term heart preservation.
Desrois M; Sciaky M; Lan C; Cozzone PJ; Bernard M
MAGMA; 1999 May; 8(2):77-82. PubMed ID: 10456368
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice.
Cross HR; Lu L; Steenbergen C; Philipson KD; Murphy E
Circ Res; 1998 Dec 14-28; 83(12):1215-23. PubMed ID: 9851938
[TBL] [Abstract][Full Text] [Related]
46. The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: a 31P, 23Na and 87Rb NMR spectroscopic study.
Cross HR; Radda GK; Clarke K
Magn Reson Med; 1995 Nov; 34(5):673-85. PubMed ID: 8544687
[TBL] [Abstract][Full Text] [Related]
47. Effects of potassium cardioplegia on high-energy phosphate kinetics during circulatory arrest with deep hypothermia in the newborn piglet heart.
Clark BJ; Woodford EJ; Malec EJ; Norwood CR; Pigott JD; Norwood WI
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):342-9. PubMed ID: 1992245
[TBL] [Abstract][Full Text] [Related]
48. Postischemic synthesis of high energy phosphates in isolated porcine hearts during reperfusion with 11 or 25 degrees C hypothermic perfluorocarbon emulsion FC 43. A 31P magnetic resonance spectroscopy study.
Scheule AM; Bohl A; Heinemann MK; Ziemer G; Henze E
Eur J Cardiothorac Surg; 1997 Apr; 11(4):746-50. PubMed ID: 9151048
[TBL] [Abstract][Full Text] [Related]
49. Noninvasive assessment of pharmaceutical intervention during myocardial ischemia-reperfusion in a canine model using two-dimensional 31P chemical shift imaging.
Campbell CM; Wisenberg G; Sykes J; Thompson RT
Biochem Cell Biol; 1998; 76(2-3):522-31. PubMed ID: 9923722
[TBL] [Abstract][Full Text] [Related]
50. Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine.
Niemann CU; Saeed M; Akbari H; Jacobsen W; Benet LZ; Christians U; Serkova N
J Pharmacol Exp Ther; 2002 Sep; 302(3):1123-8. PubMed ID: 12183671
[TBL] [Abstract][Full Text] [Related]
51. Transient adenosine infusion before ischemia and reperfusion protects against metabolic damage in pig hearts.
Yokota R; Fujiwara H; Miyamae M; Tanaka M; Yamasaki K; Itoh S; Koga K; Yabuuchi Y; Sasayama S
Am J Physiol; 1995 Mar; 268(3 Pt 2):H1149-57. PubMed ID: 7900869
[TBL] [Abstract][Full Text] [Related]
52. Mitochondrial role in ischemia-reperfusion of rat hearts exposed to high-K+ cardioplegia and clonazepam: energetic and contractile consequences.
Consolini AE; Ragone MI; Conforti P; Volonté MG
Can J Physiol Pharmacol; 2007 May; 85(5):483-96. PubMed ID: 17632582
[TBL] [Abstract][Full Text] [Related]
53. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury.
Wright GL; Hanlon P; Amin K; Steenbergen C; Murphy E; Arcasoy MO
FASEB J; 2004 Jun; 18(9):1031-3. PubMed ID: 15059965
[TBL] [Abstract][Full Text] [Related]
54. Catabolism of high energy phosphates during long-term cold storage of donor hearts: effects of extra- and intracellular fluid-type cardioplegic solutions and calcium channel blockers.
Sukehiro S; Dyszkiewics W; Minten J; Wynants J; Van Belle H; Flameng W
J Heart Lung Transplant; 1991; 10(3):387-93. PubMed ID: 1854766
[TBL] [Abstract][Full Text] [Related]
55. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts.
Illing B; Horn M; Han H; Hahn S; Bureik P; Ertl G; Neubauer S
J Cardiovasc Pharmacol; 1996 Apr; 27(4):487-94. PubMed ID: 8847864
[TBL] [Abstract][Full Text] [Related]
56. Influence of ischemic preconditioning on intracellular sodium, pH, and cellular energy status in isolated perfused heart.
Babsky A; Hekmatyar S; Wehrli S; Doliba N; Osbakken M; Bansal N
Exp Biol Med (Maywood); 2002 Jul; 227(7):520-8. PubMed ID: 12094017
[TBL] [Abstract][Full Text] [Related]
57. Cardiac hypothermia: 31P and 1H NMR spectroscopic studies of the effect of buffer on preservation of human heart atrial appendages.
Lareau S; Keon WJ; Wallace JC; Whitehead K; Mainwood GW; Deslauriers R
Can J Physiol Pharmacol; 1991 Nov; 69(11):1726-32. PubMed ID: 1666538
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of high-energy phosphate metabolism during cardioplegic arrest and reperfusion: a phosphorus-31 nuclear magnetic resonance study.
Pernot AC; Ingwall JS; Menasche P; Grousset C; Bercot M; Piwnica A; Fossel ET
Circulation; 1983 Jun; 67(6):1296-303. PubMed ID: 6851024
[TBL] [Abstract][Full Text] [Related]
59. Determination of mechanisms of myocardial ischemic injury by 31P-MRS effect of catecholamine on ischemic hearts.
Sakai H; Yoshiyama M; Teragaki M; Takeuchi K; Takeda T; Ikata M; Ishikawa M; Miura I
Biochem Biophys Res Commun; 1988 Feb; 150(3):1268-74. PubMed ID: 3342071
[TBL] [Abstract][Full Text] [Related]
60. Effects of KR-32570, a new Na+/H+ exchanger inhibitor, on functional and metabolic impairments produced by global ischemia and reperfusion in the perfused rat heart.
Lee BH; Seo HW; Yi KY; Lee S; Lee S; Yoo SE
Eur J Pharmacol; 2005 Mar; 511(2-3):175-82. PubMed ID: 15792786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
